Cardioprotective Effect of Resistance Exercise on Left Ventricular Remodeling Associated with Monocrotaline-Induced Pulmonary Arterial Hypertension

被引：0
|
作者：
Oliveira-Junior, Silvio A. [1 ]
Ogura, Alex Y. [1 ]
Carvalho, Marianna R. [1 ]
Martinez, Paula F. [1 ]
机构：
[1] Univ Fed Mato Grosso Sul UFMS, Campo Grande, MS, Brazil
来源：
ARQUIVOS BRASILEIROS DE CARDIOLOGIA | 2022年 / 119卷 / 04期
关键词：
Heart; Pulmonary Arterial Hypertension; Exercise; Myocardial Contraction; DYSFUNCTION; MODEL;
D O I：
10.36660/abc.20220638
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：585 / 586
页数：2
相关论文
共 50 条
  • [41] IDENTIFICATION OF CERB AS A MASTER TRANSCRIPTION FACTOR IN MONOCROTALINE-INDUCED PULMONARY ARTERIAL HYPERTENSION
    Xiao, Genfa
    Xie, Liangdi
    Lian, Guili
    JOURNAL OF HYPERTENSION, 2018, 36 : E15 - E15
  • [42] Cystamine slows but not inverses the progression of monocrotaline-induced pulmonary arterial hypertension in rats
    Wang, Han-Ming
    Liu, Wan-Zhu
    Tang, Fu-Tian
    Sui, Hai-Juan
    Zhan, Xing-Jie
    Wang, Hong-Xin
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 96 (08) : 783 - 789
  • [43] Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension
    Morty, Rory E.
    Nejman, Bozena
    Kwapiszewska, Grazyna
    Hecker, Matthias
    Zakrzewicz, Anka
    Kouri, Fotini M.
    Peters, Dorothea M.
    Dumitrascu, Rio
    Seeger, Werner
    Knaus, Petra
    Schermuly, Ralph T.
    Eickelberg, Oliver
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (05) : 1072 - 1078
  • [44] Cilostazol therapy attenuates monocrotaline-induced pulmonary arterial hypertension in rat model
    Chang, Li-Teh
    Sun, Cheuk-Kwan
    Sheu, Jiunn-Jye
    Chiang, Chiang-Hua
    Youssef, Ali A.
    Lee, Fan-Yen
    Wu, Chiung-Jen
    Yip, Hon-Kan
    CIRCULATION JOURNAL, 2008, 72 (05) : 825 - 831
  • [45] Inhibition of Notch3 prevents monocrotaline-induced pulmonary arterial hypertension
    Zhang, Yonghong
    Xie, Xinming
    Zhu, Yanting
    Liu, Lu
    Feng, Wei
    Pan, Yilin
    Zhai, Cui
    Ke, Rui
    Li, Shaojun
    Song, Yang
    Fan, Yuncun
    Fan, Fenling
    Wang, Xiaochuang
    Li, Fengjuan
    Li, Manxiang
    EXPERIMENTAL LUNG RESEARCH, 2015, 41 (08) : 435 - 443
  • [46] Sildenafil Limits Monocrotaline-Induced Pulmonary Hypertension in Rats Through Suppression of Pulmonary Vascular Remodeling
    Yen, Chia-Hung
    Leu, Steve
    Lin, Yu-Chun
    Kao, Ying-Hsien
    Chang, Li-Teh
    ChuaMd, Sarah
    Fu, Morgan
    Wu, Chiung-Jen
    Sun, Cheuk-Kwan
    Yip, Hon-Kan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (06) : 574 - 584
  • [47] Interventions and mechanisms of N-acetylcysteine on monocrotaline-induced pulmonary arterial hypertension
    Yu, Wencheng
    Song, Xiaoxia
    Lin, Chen
    Ji, Weina
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (06) : 5503 - 5509
  • [48] Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension
    Zhang, Ling-ling
    Lu, Jie
    Li, Meng-tao
    Wang, Qian
    Zeng, Xiao-feng
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (02) : 192 - 198
  • [49] Inhaled bosentan microparticles for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats
    Lee, Hyo-Jung
    Kwon, Yong-Bin
    Kang, Ji-Hyun
    Oh, Dong-Won
    Park, Eun-Seok
    Rhee, Yun-Seok
    Kim, Ju-Young
    Shin, Dae-Hwan
    Kim, Dong-Wook
    Park, Chun-Woong
    JOURNAL OF CONTROLLED RELEASE, 2021, 329 : 468 - 481
  • [50] Effects of inorganic nitrate in a rat model of monocrotaline-induced pulmonary arterial hypertension
    Malikova, Eva
    Carlstrom, Mattias
    Kmecova, Zuzana
    Marusakova, Margareta
    Zsigmondova, Bianka
    Krenek, Peter
    Klimas, Jan
    Henrohn, Dan
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 (02) : 99 - 109
12345